We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

202 hedge funds and large institutions have $2.28B invested in Ariad Pharmaceuticals Inc in 2016 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 63 increasing their positions, 62 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more capital invested

Capital invested by funds: $1.04B → $2.28B (+$1.25B)

69% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 29

14% more funds holding in top 10

Funds holding in top 10: 7 → 8 (+1)

11% more funds holding

Funds holding: 182 → 202 (+20)

2% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 62

26% less call options, than puts

Call options by funds: $29.1M | Put options by funds: $39.1M

Holders
202
Holders Change
+20
Holders Change %
+10.99%
% of All Funds
5.39%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.21%
New
49
Increased
63
Reduced
62
Closed
29
Calls
$29.1M
Puts
$39.1M
Net Calls
-$10M
Net Calls Change
-$11.6M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$172M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$91.1M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$59.7M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$25.5M
5
AllianceBernstein
AllianceBernstein
Tennessee
+$24.6M

Top Sellers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
-$82.3M
2
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$45.9M
3
CCM
Camber Capital Management
Massachusetts
-$29.6M
4
ECP
Elk Creek Partners
Colorado
-$11.7M
5
JIM
Jupiter Investment Management
United Kingdom
-$9.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
VEA
101
Virtus ETF Advisers
New York
$1.04M +$95.7K +9,532 +14%
VKH
102
Virtu KCG Holdings
New York
$878K -$862K -85,849 -57%
DILH
103
Dai-ichi Life Holdings
Japan
$877K +$643K +64,054 New
GCP
104
GSA Capital Partners
United Kingdom
$832K +$610K +60,778 New
RB
105
Rodgers Brothers
Pennsylvania
$801K -$5.02K -500 -0.8%
D.E. Shaw & Co
106
D.E. Shaw & Co
New York
$754K +$433K +43,129 +361%
IG
107
ING Group
Netherlands
$754K +$552K +55,000 New
TI
108
Trexquant Investment
Connecticut
$732K -$623K -62,058 -54%
MCM
109
Moore Capital Management
New York
$685K +$502K +50,000 New
SGAM
110
Steinberg Global Asset Management
Florida
$645K – – –
Legal & General Group
111
Legal & General Group
United Kingdom
$620K -$17.2K -1,715 -4%
Citadel Advisors
112
Citadel Advisors
Florida
$619K -$336K -33,478 -43%
Public Employees Retirement Association of Colorado
113
Public Employees Retirement Association of Colorado
Colorado
$595K -$60.2K -5,998 -12%
SEI Investments
114
SEI Investments
Pennsylvania
$588K -$151K -15,010 -26%
CWM
115
Concert Wealth Management
California
$558K – – –
Federated Hermes
116
Federated Hermes
Pennsylvania
$558K +$409K +40,744 New
TSS
117
Two Sigma Securities
New York
$556K +$408K +40,608 New
Royal Bank of Canada
118
Royal Bank of Canada
Ontario, Canada
$550K -$241K -24,011 -37%
EA
119
Emerald Acquisition
Washington
$535K +$392K +39,056 New
LTFS
120
Ladenburg Thalmann Financial Services
Florida
$533K – – –
HCM
121
Highbridge Capital Management
New York
$523K -$185K -18,434 -33%
SGAM
122
Smith Group Asset Management
Texas
$496K – – –
SG Americas Securities
123
SG Americas Securities
New York
$484K +$355K +35,389 New
Neuberger Berman Group
124
Neuberger Berman Group
New York
$472K +$346K +34,500 New
PA
125
Pinnacle Associates
New York
$469K +$4.62K +460 +1%
3 4
5
6 7

ARIA Hedge Fund Activity: Q3 2016 in Review

202 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q3 2016, worth a combined $2.28B — up 120% from $1.04B a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new ARIA positions and 29 closed out — a net gain of 20 holders — while 63 added to existing stakes and 62 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $172M. The largest seller was Putnam Investments, cutting an estimated $82.3M.

  • 202 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q3 2016, up from 182 in Q2 2016.
  • Funds reported $2.28B of Ariad Pharmaceuticals Inc stock for Q3 2016, up 120% quarter-over-quarter.
  • 49 funds opened new Ariad Pharmaceuticals Inc positions in Q3 2016 and 29 closed out, a net change of +20 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q3 2016 was Wellington Management Group, an estimated $172M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q3 2016 was Putnam Investments, an estimated $82.3M sold.

Based on aggregated 13F filings for Q3 2016.